News Novavax, Inc.

Equities

NVAX

US6700024010

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
15.5 ^USD	+2.31%		+19.14%	+222.92%

May. 24	Novavax awaits FDA decision on whether its next COVID shot can be offered in US	RE
May. 23	Novavax, Inc. Notifies Retirement of Filip Dubovsky as President, Research and Development, Effective as of June 30, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novavax awaits FDA decision on whether its next COVID shot can be offered in US	May. 24	RE
Novavax, Inc. Notifies Retirement of Filip Dubovsky as President, Research and Development, Effective as of June 30, 2024	May. 23	CI
B. Riley Boosts Price Target on Novavax to $29 From $11, Maintains Buy Rating	May. 23	MT
Novavax: 1st shipment of R21/MatrixM malaria vaccine	May. 21	CF
Serum Institute of India Ships Its First Set of R21/Matrix-M? Malaria Vaccine Doses to Africa [press release]	May. 20	AQ
Global markets live: Apple, Tesla, Pfizer, AstraZeneca, Microsoft...	May. 20
Focus on Nvidia	May. 20
Shah Capital ends campaign against Novavax board after Sanofi deal	May. 20	RE
Novavax Stockholder Shah Capital Withdraws Campaign Against Reelection of Directors	May. 20	MT
Shah Capital withdraws campaign against Novavax directors after Sanofi deal	May. 20	RE
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting	May. 20	AQ
Shah Capital withdraws campaign against three Novavax directors	May. 20	RE
Shah Capital Management Announces Withdrawal of Nominations	May. 20	CI
Transcript : Novavax, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 03:00 PM	May. 15
Global markets live: Apple, Sony, Vodafone, Booking, Walmart...	May. 14
Social Buzz: Wallstreetbets Stocks Mostly Higher Pre-Bell Tuesday; AMC Entertainment, GameStop to Advance	May. 14	MT
Novavax to Participate in BofA Securities 2024 Health Care Conference	May. 13	PR
Novavax Shares Pop Another 50% Following Sanofi Deal	May. 13	DJ
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccines	May. 13	AQ
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights	May. 13	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Novavax Surges on $1.2 Billion Sanofi Vaccine Deal

May 10, 2024 at 02:52 pm EDT